• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

byYuchen DaiandMichael Pratte
June 16, 2022
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Compared to mammography, screening with digital breast tomosynthesis was not associated with a significant difference in risk of interval invasive cancer and associated with a significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer.

2. No significant difference was observed in women with nondense breasts, heterogeneously dense breasts, or with extremely dense breasts not at high risk.

Evidence Rating Level: 2 (Good)

Study Rundown: Digital breast tomosynthesis (DBT) is a breast imaging modality commonly used in women with dense breasts to help improve cancer detection. Due to a lack of current data, this cohort study evaluated whether DBT vs digital mammography is associated with a lower risk of interval invasive cancer, advanced breast cancer, and false positives among women undergoing routine screening by extent of breast density and breast cancer risk. Key outcomes included rates of interval invasive cancer within 12 months of screening mammography and advanced breast cancer within 12 months of screening mammography. Among 504 427 women screened, interval cancer rates were not significantly different for DBT vs digital mammography. However, in a subset of women with extremely dense breasts and high risk of breast cancer, advanced cancer rates for DBT vs digital mammography were 0.27 vs 0.80 per 1000 examinations, respectively (statistically significant). Among women with nondense breasts, heterogeneously dense breasts, or extremely dense breasts with low to average risk of breast cancer, no significant differences in advanced cancer rates were observed. A limitation of this study was ensuring that risk factors and demographics were comparable for both imaging groups for accurate outcomes assessment.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

Increasing cancer incidence rates in younger and older adults worldwide

Punjab launches AI screening program this week

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

Relevant Reading: Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 years of breast cancer screening

In-Depth [prospective cohort]: This cohort study included 504 427 women (median age [IQR], 58 [50-65] years) undergoing screening digital mammography and DBT examinations from 2011-2018 at 44 US Breast Cancer Surveillance Consortium (BCSC) facilities with follow-up through 2019. Overall, interval invasive cancer rates per 1000 examinations were not significantly different for DBT (0.57) vs digital mammography (0.61) (difference, −0.04; 95%CI, −0.14 to 0.06; P = .43) or among patients with low to average risk or high risk across breast density categories. Compared to digital mammography, advanced cancer rates per 1000 examinations were significantly lower for DBT for women with extremely dense breasts at high risk of breast cancer (0.27 vs 0.80; difference, −0.53; 95%CI, −0.97 to −0.10), but not for women at low to average risk (0.54 vs 0.42; difference, 0.12; 95%CI, −0.09 to 0.32).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerdigital breast tomosynthesismammography
Previous Post

INPULSIS: Nintedanib for Idiopathic Pulmonary Fibrosis [Classics Series]

Next Post

Wellness Check: Spirituality

RelatedReports

Population-based risk factors and geographical trends identified for vitiligo
Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025
Blindness and visual impairment decreasing worldwide
AI Roundup

Punjab launches AI screening program this week

September 30, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Endocrinology

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

August 28, 2025
Next Post

Wellness Check: Spirituality

Interstitial lung abnormalities linked to greater risk of all-cause mortality

Phosphodiesterase 4 inhibitor BI 1015550 preserves lung function in pulmonary fibrosis patients

Novel coronavirus identified from patients with pneumonia in Wuhan, China

High burden of persistent symptoms seen in patients after COVID-19 recovery

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit
  • Risk of infection and wound dehiscence after use of prophylactic antibiotics in episiotomy or second degree tear (REPAIR study): single centre, double blind, placebo-controlled randomised trial
  • 2 Minute Medicine Rewind November 3rd, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.